Search
Now showing items 1-1 of 1
Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 – 2023)
(Elsevier, 2022)
Namibia started implementing pre-exposure prophylaxis (PrEP) of Human
Immunodeficiency Virus (HIV) in 2016, no study to determine its budget impact has been conducted. This
study, therefore, aimed to estimate the budget ...